Figure 6.
Potential predictive value of CASP6 in chemotherapy and immunotherapy in the CGGA database. (A) IC50 of temozolomide in the low and high CASP6 expression groups. Low CASP6 expression group (n = 326), high CASP6 expression group (n = 325) (B) Immunotherapy responses in the low and high CASP6 expression groups. Low CASP6 expression group [response: n = 207, (63.50%); non-response: n = 119, (36.50%)], high CASP6 expression group (response: n = 119, (36.62%); non-response: n = 206, (63.38%)) *** P < 0.001.